Nanobiotix unveils “promising” data from its head and neck cancer trial at ASCO 2017 - Proactive Investors UK

Proactive Investors UK

Nanobiotix unveils “promising” data from its head and neck cancer trial at ASCO 2017 Proactive Investors UK Nanobiotix SA (EPA:NANO) unveiled some promising data from the recent phase I/II head and neck cancer trial of its lead candidate, NBTXR3, at the American Society of Clinical Oncology (ASCO) in Chicago over the weekend. The early-stage study was ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2r1uYt0
via IFTTT